Early Phase Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Early Phase Trials in Brazil

Early Phase Trials in Brazil – Full Service CRO

Clinical trials are crucial for advancing medical research and improving patient care. Brazil has emerged as a prominent destination for early phase trials, offering a conducive environment for groundbreaking research. With its strong healthcare infrastructure, diverse patient population, and supportive regulatory framework, Brazil has become an attractive hub for conducting innovative studies.

In this blog post, we will explore the significance of early phase trials in Brazil, the benefits they bring to both patients and researchers, the regulatory landscape governing these trials, and notable examples of pioneering research conducted in the country.

The Significance of Early Phase Trials

Early phase trials, comprising phase I and phase II studies, play a critical role in the drug development process. These trials primarily focus on assessing the safety, dosage range, and initial efficacy of investigational drugs in human subjects. Through early phase trials, researchers gain valuable insights into drug pharmacokinetics, potential side effects, and preliminary efficacy, shaping the direction of further research and potential regulatory approval.

Advantages of Conducting Early Phase Trials in Brazil

Brazil offers several distinct advantages for conducting early phase trials. Firstly, the country possesses a large and diverse patient population, encompassing a broad range of ethnicities and genetic backgrounds. This diversity enables researchers to gather comprehensive data and ensure the generalizability of research findings to broader populations.

Additionally, Brazil’s healthcare infrastructure is well-developed, with numerous research institutions, academic medical centers, and clinical trial sites. These facilities are equipped with state-of-the-art technology and staffed by highly trained healthcare professionals, ensuring optimal patient care and trial execution.

The regulatory landscape in Brazil also facilitates early phase trials. The Brazilian Health Regulatory Agency (ANVISA) oversees the approval and regulation of clinical trials, adhering to international standards and guidelines. ANVISA’s streamlined processes prioritize patient safety, ethical conduct, and data confidentiality.

Benefits to Patients and Researchers

Early phase trials in Brazil offer significant benefits to both patients and researchers. For patients, participating in these trials provides access to potentially life-changing treatments not yet available on the market. Patients receive close medical supervision, ensuring their well-being and the prompt identification and management of any adverse effects. This personalized care enhances patient safety and fosters a sense of empowerment through active participation in their own healthcare.

Furthermore, early phase trials often provide compensation for patients’ time and travel expenses, reducing the financial burden associated with participation. By enrolling in these trials, patients contribute to scientific knowledge and the development of innovative therapies, playing a crucial role in advancing medical research.

For researchers, Brazil’s large and diverse patient population presents a valuable opportunity for efficient recruitment and enrollment. The diverse patient cohorts enhance the understanding of treatment responses across different demographics and genetic backgrounds. Collaborating with Brazilian research institutions also grants access to local expertise, fostering international collaborations and knowledge exchange.

Early Phase Trials in Brazil

Early Phase Trials in Brazil

Early Phase Trials in Brazil

Groundbreaking Research in Brazil

Brazil has been at the forefront of pioneering research in various medical fields through early phase trials. Notably, the country has made significant contributions to the development of vaccines, such as those against dengue and yellow fever. Extensive phase II trials conducted in Brazil have provided valuable data on vaccine safety, efficacy, and immunogenicity.

Moreover, Brazil has played a crucial role in the advancement of treatments for neglected tropical diseases. Early phase trials evaluating innovative therapies and drug combinations have shown promising results, improving the outlook for patients affected by these challenging conditions.


Early phase trials in Brazil have become a driving force in medical innovation, attracting researchers and benefiting patients. The country’s advantages, including its diverse patient population, robust healthcare infrastructure, and supportive regulatory framework, have positioned Brazil as a leading destination for cutting-edge research.

Participation in early phase trials grants patients access to potentially life-changing treatments while actively contributing to the development of innovative therapies. Researchers benefit from Brazil’s favorable research environment, allowing for efficient recruitment, diverse patient cohorts, and collaborative partnerships.

As early phase trials continue to flourish in Brazil, the country will undoubtedly contribute to the advancement of medical knowledge, improving patient care on a global scale. With ongoing commitment to excellence, Brazil’s research community will shape the future of medicine and bring hope to patients in need.

Early Phase Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Early Phase Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Early Phase Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Early Phase Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Early Phase Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Early Phase Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Early Phase Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Early Phase Trials in Brazil

The Cohortias Team

Early Phase Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Early Phase Trials in Brazil

Network & Partnerships